Webcast ImageWebcast
Q4 2017 Laboratory Corporation of America Holdings Earnings Conference Call (Live)
02/06/18 at 9:00 a.m. ET
E-mail Alerts Receive E-mail Alerts | RSS RSS Feeds
Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
01/19/18LabCorp Named to FORTUNE Magazine's 2018 List of ‘World’s Most Admired Companies’
BURLINGTON, N.C.--(BUSINESS WIRE)--Jan. 19, 2018-- Laboratory Corporation of America® Holdings (LabCorp) (NYSE: LH), a leading global life sciences company, today announced that it has been named to FORTUNE magazine's 2018 List of World’s Most Admired Companies. The annual survey, conducted by FORTUNE and the Hay Group division of Korn Ferry, a global people and organizational advisory firm, is given to top executives, directors and financial anal... 
Printer Friendly Version
01/08/18Covance Introduces Dedicated Offering Designed for Biotech, Medical Device and Diagnostics Companies
Distinctive development solutions provided by Chiltern®, a Covance® company BURLINGTON, N.C.--(BUSINESS WIRE)--Jan. 8, 2018-- LabCorp® (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business has introduced a dedicated offering for biotech, medical device and diagnostics companies from Chiltern®, a Covance® company. This unique offering follows the acquisition of Chiltern, a leadi... 
Printer Friendly Version
01/03/18LabCorp is Scheduled to Present at the 36th Annual J.P. Morgan Healthcare Conference
BURLINGTON, N.C.--(BUSINESS WIRE)--Jan. 3, 2018-- LabCorp® (NYSE: LH) today announced it will participate at the 36th Annual J.P. Morgan Healthcare Conference. LabCorp’s presentation is scheduled for Tuesday, January 9, 2018 at 9:30 am (PT). A live audio webcast of the presentation will be available via the Company website at www.labcorp.com and archived for replay. About LabCorp LabCorp (NYSE: LH), an S&P 500 co... 
Printer Friendly Version
01/02/18Conversion Right Triggered For LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
BURLINGTON, N.C.--(BUSINESS WIRE)--Jan. 2, 2018-- LabCorp® (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject to the terms of the Zero Coupon Notes and the Indenture, dated as of October 24, 2006 between LabCorp and The Bank of New York Mellon, as trustee ... 
Printer Friendly Version
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Tear Sheet